4521.T
4521.T
JP3207000005
KAKEN PHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 76.871.000.000 94.035.000.000
18.3%
Cost of Revenue 36.879.000.000 35.502.000.000
3.9%
Gross Profit 39.991.000.000 58.532.000.000
31.7%
40.888.000.000 37.494.000.000
9.1%
Operating Income -897.000.000 21.038.000.000
104.3%
Pretax Income 2.313.000.000 19.435.000.000
88.1%
Net Income Common Stockholders 2.144.000.000 13.945.000.000
84.6%
-- --
--
-- --
--
ende